allorx stem cells®
Cell therapyexperimental
Clinical trial activity
28 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
28
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2021 (NCT05003921)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Amyotrophic Lateral Sclerosis · Phase 1
- Angina Pectoris · Phase 1
- Arthritis, Rheumatoid · Phase 1
- Asthma · Phase 1
- Autistic Disorder · Phase 1
- Brain Injuries, Traumatic · Phase 1
- Cerebral Palsy · Phase 1
- Cystitis, Interstitial · Phase 1
- Diabetes Mellitus · Phase 1
- Diabetic Retinopathy · Phase 1
- Erectile Dysfunction · Phase 1
- Eye Diseases · Phase 1
- Frailty · Phase 1
- Glaucoma · Phase 1
- Heart Failure · Phase 1
- Idiopathic Pulmonary Fibrosis · Phase 1
- Inflammatory Bowel Diseases · Phase 1
- Intellectual Disability · Phase 1/Phase 2
- Lung Diseases · Phase 1
- Lupus Erythematosus, Systemic · Phase 1
- Macular Degeneration · Phase 1
- Multiple Sclerosis · Phase 1
- Oligospermia · Phase 1
- Optic Atrophy · Phase 1
- Optic Nerve Injuries · Phase 1
- Osteoarthritis · Phase 1
- Osteoporosis · Phase 1
- Ovarian Diseases · Phase 1
- Parkinson Disease · Phase 1
- Penile Induration · Phase 1
- Peripheral Nervous System Diseases · Phase 1
- Pulmonary Disease, Chronic Obstructive · Phase 1
- Renal Insufficiency, Chronic · Phase 1
- Retinitis Pigmentosa · Phase 1
- Scleroderma, Systemic · Phase 1
- Skin Ulcer · Phase 1
- Spinal Cord Injuries · Phase 1
- Spondylarthritis · Phase 1
- Stroke · Phase 1
- Testicular Diseases · Phase 1
- Tourette Syndrome · Phase 1
- Trigeminal Neuralgia · Phase 1
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05147766 | Phase 1 | Feb 28, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05158101 | Phase 1 | Feb 28, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05158439 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05158127 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05158114 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05147701 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05152394 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05152381 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05152368 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05152290 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05158933 | Phase 1 | Jan 31, 2022 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05165017 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2021 | Vitro Biopharma Inc. |
| NCT05147675 | Phase 1 | Dec 31, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05147688 | Phase 1 | Dec 31, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05147779 | Phase 1 | Dec 31, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05003908 | Phase 1 | Nov 30, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05018832 | Phase 1 | Nov 30, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05018819 | Phase 1 | Nov 30, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05018767 | Phase 1 | Nov 30, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
| NCT05016804 | Phase 1 | Nov 30, 2021 | The Foundation for Orthopaedics and Regenerative Medicine |
Showing 20 of 28 trials
Page 1 / 2
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The Foundation for Orthopaedics and Regenerative Medicine | Academic/Hospital | 27 | 27 | 1 | 2021 |
| Vitro Biopharma Inc. | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1